Medicalgorithmics has signed a strategic distribution agreement with Express Diagnostics Limited, the company said. Express Diagnostics is the largest provider of heart monitoring and ECG analysis services in the UK. The agreement covers the distribution of PocketECG and AI, including in the future Deep Rhythm AI and analytics technologies.
“In the opinion of the company’s management, the conclusion of the agreement with Express Diagnostics and thus entering the British market is the result of the new strategy of dynamic expansion on global markets announced last year at the time of the merger with Biofund.” – we read in the press release.
Medicalgorithmics is a Polish high-tech company present on the market since 2005, operating in the field of non-invasive medical devices. The Group strives to become a leading provider of system and algorithmic solutions in cardiological diagnostics, in particular in the field of ECG signal analysis. The company operates in, among others, the USA and Asia. In 2014, the company moved to the main market of the Warsaw Stock Exchange from NewConnect, where it had been listed since 2011.